Qiagen NV (NYSE:QGEN) currently has a daily average trading volume of 1.35M but it saw 1284623 shares traded in last market. With a market cap of 9.15B USD, the company’s current market price of $42.32 remained unchanged while comparing to the previous closing price of $42.32. In past 52 weeks, the stock remained buoying in the range of price level as high as $47.92 and as low as $37.63.
Robert W. Baird downgraded its recommendation for the stock as a “Neutral” from “Outperform” on February 19, 2025 while assigning a price target range of $52-$42. Morgan Stanley also issued its recommendations for the stock as it downgraded the price target for the stock is $48.
Over the week, QGEN’s stock price is moving 0.19% up while it is 0.00% when we observe its performance for the past one month. Year-to-date it is -4.95% down and over the past year, the stock is showing a downside performance of -6.91%.
Currently, Qiagen NV’s total number of outstanding shares is 216.56M with 1.61% of that held by the insiders while 78.99% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 1.97% and return on equity (ROE) at 2.67%. It has a price to earnings ratio (P/E ratio) of 101.39 while having a 16.81 of forward P/E ratio. Stock’s beta reads 0.66. Stock has a price to book (P/B) ratio of 2.69 while price to sale or P/S ratio amounts to 4.57. Its return on asset (ROA) is 1.65% on average.
